---
title: "Novartis and Takeda drugs gain rare blood cancer routine use on NHS"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293229662.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-20T10:46:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293229662.md)
  - [en](https://longbridge.com/en/news/293229662.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293229662.md)
generator: "portal-rs"
---

# Novartis and Takeda drugs gain rare blood cancer routine use on NHS

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [4502.JP](https://longbridge.com/en/quote/4502.JP.md)
- [TAK.US](https://longbridge.com/en/quote/TAK.US.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [NOT.DE](https://longbridge.com/en/quote/NOT.DE.md)

## Related News & Research

- [Takeda President, R&D Andrew Plump sells 116,191 ADS for $2.15 million](https://longbridge.com/en/news/297977753.md)
- [Takeda and Weave Bio collaborate on AI-driven automation in drug development](https://longbridge.com/en/news/297762467.md)
- [Novartis Just Lost a Potential $6 Billion Drug Opportunity](https://longbridge.com/en/news/298222548.md)
- [Novartis announces Phase 3 pelacarsen study did not meet primary endpoint](https://longbridge.com/en/news/298086918.md)
- [Pharma brands dominated last NFL advertising season: report](https://longbridge.com/en/news/297787053.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**